The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Transdermal & Transmucosal Drug Delivery System Market Research Report 2025
Synopsis
Transdermal/transmucosal drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. Transdermal/transmucosal drug delivery continues to play an important role in the development of a variety of therapeutic areas in both brand and generic products.
The global Transdermal & Transmucosal Drug Delivery System market was valued at US$ 25420 million in 2023 and is anticipated to reach US$ 32660 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
A significant driver in the transdermal and transmucosal drug delivery system market is the demand for convenient and non-invasive drug administration methods. These systems offer painless and patient-friendly alternatives to traditional oral or injectable routes, improving medication adherence and patient comfort. However, a notable challenge in this market is the formulation complexity and variability in patient responses. Developing effective drug delivery systems that consistently deliver precise dosages and account for individual variations in skin or mucosal permeability presents a challenge. Manufacturers must focus on optimizing formulations and ensuring predictable drug release to maximize the potential of transdermal and transmucosal drug delivery systems in providing efficient and patient-centered healthcare solutions.
This report aims to provide a comprehensive presentation of the global market for Transdermal & Transmucosal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal & Transmucosal Drug Delivery System.
Report Scope
The Transdermal & Transmucosal Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal & Transmucosal Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal & Transmucosal Drug Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
Viatris
Teva
Zosano Pharma
Segment by Type
Transdermal Drug Delivery System
Transmucosal Drug Delivery System
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transdermal & Transmucosal Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transdermal & Transmucosal Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Transdermal/transmucosal drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. Transdermal/transmucosal drug delivery continues to play an important role in the development of a variety of therapeutic areas in both brand and generic products.
The global Transdermal & Transmucosal Drug Delivery System market was valued at US$ 25420 million in 2023 and is anticipated to reach US$ 32660 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
A significant driver in the transdermal and transmucosal drug delivery system market is the demand for convenient and non-invasive drug administration methods. These systems offer painless and patient-friendly alternatives to traditional oral or injectable routes, improving medication adherence and patient comfort. However, a notable challenge in this market is the formulation complexity and variability in patient responses. Developing effective drug delivery systems that consistently deliver precise dosages and account for individual variations in skin or mucosal permeability presents a challenge. Manufacturers must focus on optimizing formulations and ensuring predictable drug release to maximize the potential of transdermal and transmucosal drug delivery systems in providing efficient and patient-centered healthcare solutions.
This report aims to provide a comprehensive presentation of the global market for Transdermal & Transmucosal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal & Transmucosal Drug Delivery System.
Report Scope
The Transdermal & Transmucosal Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal & Transmucosal Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal & Transmucosal Drug Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
Viatris
Teva
Zosano Pharma
Segment by Type
Transdermal Drug Delivery System
Transmucosal Drug Delivery System
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transdermal & Transmucosal Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transdermal & Transmucosal Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Transdermal & Transmucosal Drug Delivery System Market Overview
1.1 Product Overview and Scope of Transdermal & Transmucosal Drug Delivery System
1.2 Transdermal & Transmucosal Drug Delivery System Segment by Type
1.2.1 Global Transdermal & Transmucosal Drug Delivery System Market Value Comparison by Type (2024-2030)
1.2.2 Transdermal Drug Delivery System
1.2.3 Transmucosal Drug Delivery System
1.3 Transdermal & Transmucosal Drug Delivery System Segment by Application
1.3.1 Global Transdermal & Transmucosal Drug Delivery System Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Transdermal & Transmucosal Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global Transdermal & Transmucosal Drug Delivery System Revenue 2019-2030
1.4.2 Global Transdermal & Transmucosal Drug Delivery System Sales 2019-2030
1.4.3 Global Transdermal & Transmucosal Drug Delivery System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Transdermal & Transmucosal Drug Delivery System Market Competition by Manufacturers
2.1 Global Transdermal & Transmucosal Drug Delivery System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Transdermal & Transmucosal Drug Delivery System Average Price by Manufacturers (2019-2024)
2.4 Global Transdermal & Transmucosal Drug Delivery System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transdermal & Transmucosal Drug Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal & Transmucosal Drug Delivery System, Product Type & Application
2.7 Transdermal & Transmucosal Drug Delivery System Market Competitive Situation and Trends
2.7.1 Transdermal & Transmucosal Drug Delivery System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Transdermal & Transmucosal Drug Delivery System Players Market Share by Revenue
2.7.3 Global Transdermal & Transmucosal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transdermal & Transmucosal Drug Delivery System Retrospective Market Scenario by Region
3.1 Global Transdermal & Transmucosal Drug Delivery System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Transdermal & Transmucosal Drug Delivery System Global Transdermal & Transmucosal Drug Delivery System Sales by Region: 2019-2030
3.2.1 Global Transdermal & Transmucosal Drug Delivery System Sales by Region: 2019-2024
3.2.2 Global Transdermal & Transmucosal Drug Delivery System Sales by Region: 2025-2030
3.3 Global Transdermal & Transmucosal Drug Delivery System Global Transdermal & Transmucosal Drug Delivery System Revenue by Region: 2019-2030
3.3.1 Global Transdermal & Transmucosal Drug Delivery System Revenue by Region: 2019-2024
3.3.2 Global Transdermal & Transmucosal Drug Delivery System Revenue by Region: 2025-2030
3.4 North America Transdermal & Transmucosal Drug Delivery System Market Facts & Figures by Country
3.4.1 North America Transdermal & Transmucosal Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Transdermal & Transmucosal Drug Delivery System Sales by Country (2019-2030)
3.4.3 North America Transdermal & Transmucosal Drug Delivery System Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transdermal & Transmucosal Drug Delivery System Market Facts & Figures by Country
3.5.1 Europe Transdermal & Transmucosal Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Transdermal & Transmucosal Drug Delivery System Sales by Country (2019-2030)
3.5.3 Europe Transdermal & Transmucosal Drug Delivery System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal & Transmucosal Drug Delivery System Market Facts & Figures by Country
3.6.1 Asia Pacific Transdermal & Transmucosal Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Transdermal & Transmucosal Drug Delivery System Sales by Country (2019-2030)
3.6.3 Asia Pacific Transdermal & Transmucosal Drug Delivery System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Transdermal & Transmucosal Drug Delivery System Market Facts & Figures by Country
3.7.1 Latin America Transdermal & Transmucosal Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Transdermal & Transmucosal Drug Delivery System Sales by Country (2019-2030)
3.7.3 Latin America Transdermal & Transmucosal Drug Delivery System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal & Transmucosal Drug Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal & Transmucosal Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Transdermal & Transmucosal Drug Delivery System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Transdermal & Transmucosal Drug Delivery System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Transdermal & Transmucosal Drug Delivery System Sales by Type (2019-2030)
4.1.1 Global Transdermal & Transmucosal Drug Delivery System Sales by Type (2019-2024)
4.1.2 Global Transdermal & Transmucosal Drug Delivery System Sales by Type (2025-2030)
4.1.3 Global Transdermal & Transmucosal Drug Delivery System Sales Market Share by Type (2019-2030)
4.2 Global Transdermal & Transmucosal Drug Delivery System Revenue by Type (2019-2030)
4.2.1 Global Transdermal & Transmucosal Drug Delivery System Revenue by Type (2019-2024)
4.2.2 Global Transdermal & Transmucosal Drug Delivery System Revenue by Type (2025-2030)
4.2.3 Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share by Type (2019-2030)
4.3 Global Transdermal & Transmucosal Drug Delivery System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Transdermal & Transmucosal Drug Delivery System Sales by Application (2019-2030)
5.1.1 Global Transdermal & Transmucosal Drug Delivery System Sales by Application (2019-2024)
5.1.2 Global Transdermal & Transmucosal Drug Delivery System Sales by Application (2025-2030)
5.1.3 Global Transdermal & Transmucosal Drug Delivery System Sales Market Share by Application (2019-2030)
5.2 Global Transdermal & Transmucosal Drug Delivery System Revenue by Application (2019-2030)
5.2.1 Global Transdermal & Transmucosal Drug Delivery System Revenue by Application (2019-2024)
5.2.2 Global Transdermal & Transmucosal Drug Delivery System Revenue by Application (2025-2030)
5.2.3 Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share by Application (2019-2030)
5.3 Global Transdermal & Transmucosal Drug Delivery System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Corporation Information
6.1.2 3M Description and Business Overview
6.1.3 3M Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 3M Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Antares Pharma
6.2.1 Antares Pharma Corporation Information
6.2.2 Antares Pharma Description and Business Overview
6.2.3 Antares Pharma Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Antares Pharma Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.2.5 Antares Pharma Recent Developments/Updates
6.3 Aveva Drug Delivery Systems
6.3.1 Aveva Drug Delivery Systems Corporation Information
6.3.2 Aveva Drug Delivery Systems Description and Business Overview
6.3.3 Aveva Drug Delivery Systems Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aveva Drug Delivery Systems Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.3.5 Aveva Drug Delivery Systems Recent Developments/Updates
6.4 Corium International
6.4.1 Corium International Corporation Information
6.4.2 Corium International Description and Business Overview
6.4.3 Corium International Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Corium International Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.4.5 Corium International Recent Developments/Updates
6.5 DURECT
6.5.1 DURECT Corporation Information
6.5.2 DURECT Description and Business Overview
6.5.3 DURECT Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 DURECT Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.5.5 DURECT Recent Developments/Updates
6.6 Pantec Biosolutions
6.6.1 Pantec Biosolutions Corporation Information
6.6.2 Pantec Biosolutions Description and Business Overview
6.6.3 Pantec Biosolutions Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pantec Biosolutions Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.6.5 Pantec Biosolutions Recent Developments/Updates
6.7 Tapemark
6.6.1 Tapemark Corporation Information
6.6.2 Tapemark Description and Business Overview
6.6.3 Tapemark Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tapemark Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.7.5 Tapemark Recent Developments/Updates
6.8 Tesa Labtec
6.8.1 Tesa Labtec Corporation Information
6.8.2 Tesa Labtec Description and Business Overview
6.8.3 Tesa Labtec Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Tesa Labtec Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.8.5 Tesa Labtec Recent Developments/Updates
6.9 Viatris
6.9.1 Viatris Corporation Information
6.9.2 Viatris Description and Business Overview
6.9.3 Viatris Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Viatris Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.9.5 Viatris Recent Developments/Updates
6.10 Teva
6.10.1 Teva Corporation Information
6.10.2 Teva Description and Business Overview
6.10.3 Teva Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Teva Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.10.5 Teva Recent Developments/Updates
6.11 Zosano Pharma
6.11.1 Zosano Pharma Corporation Information
6.11.2 Zosano Pharma Transdermal & Transmucosal Drug Delivery System Description and Business Overview
6.11.3 Zosano Pharma Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zosano Pharma Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.11.5 Zosano Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal & Transmucosal Drug Delivery System Industry Chain Analysis
7.2 Transdermal & Transmucosal Drug Delivery System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal & Transmucosal Drug Delivery System Production Mode & Process
7.4 Transdermal & Transmucosal Drug Delivery System Sales and Marketing
7.4.1 Transdermal & Transmucosal Drug Delivery System Sales Channels
7.4.2 Transdermal & Transmucosal Drug Delivery System Distributors
7.5 Transdermal & Transmucosal Drug Delivery System Customers
8 Transdermal & Transmucosal Drug Delivery System Market Dynamics
8.1 Transdermal & Transmucosal Drug Delivery System Industry Trends
8.2 Transdermal & Transmucosal Drug Delivery System Market Drivers
8.3 Transdermal & Transmucosal Drug Delivery System Market Challenges
8.4 Transdermal & Transmucosal Drug Delivery System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
